A Cornell University-led collaboration has uncovered the equipment that enables bacteria to survive exposure to antibiotics: ...

Today, antibiotics are the third largest-selling ... manufactured by Micrologix Biotech (Vancouver, BC). The two-part phase II trials are intended to assess the safety, pharmacokinetics, and ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

By analyzing E. coli protein levels, scientists found a surplus of membrane shuttle proteins that may play a role in antibiotic resistance.

While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

Antibiotics are indispensable for treating bacterial infections. But why are they sometimes ineffective, even when the bacteria are not resistant? In their latest study, researchers challenge the ...

Shorter, smarter, safer: Short-course antibiotics can revolutionize healthcare Date: January 21, 2025 Source: National University of Singapore, Yong Loo Lin School of Medicine Summary: Antibiotic ...

tuberculosis.” UC San Diego biotech spinoff tackles global health issue Linnaeus Bioscience was launched in 2012 with a UC ...

Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...

The data suggests that the body's use of nutrient scarcity as a defense mechanism may actually enable bacteria's survival in the long run.

The Basel-based biotech company BioVersys made the first initial public offering (IPO) of the year in Switzerland on Friday. Shares started trading ...